Meir Goldsmith

2.8k total citations
35 papers, 2.0k citations indexed

About

Meir Goldsmith is a scholar working on Molecular Biology, Immunology and Cancer Research. According to data from OpenAlex, Meir Goldsmith has authored 35 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Biology, 12 papers in Immunology and 6 papers in Cancer Research. Recurrent topics in Meir Goldsmith's work include RNA Interference and Gene Delivery (22 papers), Advanced biosensing and bioanalysis techniques (11 papers) and Immunotherapy and Immune Responses (8 papers). Meir Goldsmith is often cited by papers focused on RNA Interference and Gene Delivery (22 papers), Advanced biosensing and bioanalysis techniques (11 papers) and Immunotherapy and Immune Responses (8 papers). Meir Goldsmith collaborates with scholars based in Israel, United States and Germany. Meir Goldsmith's co-authors include Dan Peer, Srinivas Ramishetti, Dalit Landesman‐Milo, Nuphar Veiga, Vincent M. Rotello, Daniel F. Moyano, Oscar R. Miranda, Niels Dammes, Ranit Kedmi and Daniel Rosenblum and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Advanced Materials.

In The Last Decade

Meir Goldsmith

35 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Meir Goldsmith Israel 22 1.4k 462 455 391 182 35 2.0k
Jeonghwan Kim South Korea 23 1.8k 1.3× 377 0.8× 460 1.0× 402 1.0× 383 2.1× 48 2.7k
Yuriko Higuchi Japan 28 1.5k 1.1× 310 0.7× 393 0.9× 545 1.4× 346 1.9× 86 2.2k
Sean A. Dilliard United States 8 2.2k 1.7× 422 0.9× 452 1.0× 441 1.1× 377 2.1× 9 2.8k
Ying‐Li Luo China 22 1.1k 0.8× 440 1.0× 407 0.9× 625 1.6× 185 1.0× 37 1.9k
Thomas Schluep United States 24 1.2k 0.9× 216 0.5× 645 1.4× 453 1.2× 209 1.1× 47 2.6k
Xiangang Huang China 29 1.7k 1.2× 475 1.0× 483 1.1× 951 2.4× 222 1.2× 44 2.9k
Scott Barros United States 14 1.8k 1.4× 291 0.6× 372 0.8× 321 0.8× 244 1.3× 20 2.4k
Srinivas Ramishetti Israel 27 2.1k 1.6× 642 1.4× 494 1.1× 503 1.3× 372 2.0× 44 2.8k
Anna Riccioli Italy 26 980 0.7× 782 1.7× 525 1.2× 312 0.8× 114 0.6× 43 2.4k
Xinyao Du United States 6 2.3k 1.7× 411 0.9× 407 0.9× 304 0.8× 284 1.6× 6 2.7k

Countries citing papers authored by Meir Goldsmith

Since Specialization
Citations

This map shows the geographic impact of Meir Goldsmith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meir Goldsmith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meir Goldsmith more than expected).

Fields of papers citing papers by Meir Goldsmith

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meir Goldsmith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meir Goldsmith. The network helps show where Meir Goldsmith may publish in the future.

Co-authorship network of co-authors of Meir Goldsmith

This figure shows the co-authorship network connecting the top 25 collaborators of Meir Goldsmith. A scholar is included among the top collaborators of Meir Goldsmith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meir Goldsmith. Meir Goldsmith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zilberzwige‐Tal, Shai, Aviad Levin, Assaf Ezra, et al.. (2025). On‐Chip De Novo Production of mRNA Vaccine in Lipid Nanoparticles. Small. 21(32). e2500114–e2500114. 1 indexed citations
2.
Ad‐El, Nitay, Meir Goldsmith, Anna Gutkin, et al.. (2025). Low-frequency ultrasound-mediated blood-brain barrier opening enables non-invasive lipid nanoparticle RNA delivery to glioblastoma. Journal of Controlled Release. 385. 114018–114018. 4 indexed citations
3.
Naidu, Gonna Somu, Meir Goldsmith, Riccardo Rampado, et al.. (2025). Targeting intestinal inflammation using locked nucleic acids delivered via lipid nanoparticles. Nature Communications. 16(1). 7682–7682. 2 indexed citations
4.
Stotsky‐Oterin, Lior, Nitay Ad‐El, Gonna Somu Naidu, et al.. (2024). Targeted CRISPR/Cas9 Lipid Nanoparticles Elicits Therapeutic Genome Editing in Head and Neck Cancer. Advanced Science. 12(7). e2411032–e2411032. 11 indexed citations
5.
Rampado, Riccardo, et al.. (2024). Lipid Nanoparticles With Fine‐Tuned Composition Show Enhanced Colon Targeting as a Platform for mRNA Therapeutics. Advanced Science. 12(3). e2408744–e2408744. 10 indexed citations
6.
Naidu, Gonna Somu, Seok‐Beom Yong, Srinivas Ramishetti, et al.. (2023). A Combinatorial Library of Lipid Nanoparticles for Cell Type‐Specific mRNA Delivery. Advanced Science. 10(19). e2301929–e2301929. 73 indexed citations
7.
Hazan‐Halevy, Inbal, Meir Goldsmith, Lior Stotsky‐Oterin, et al.. (2023). Delivery of Therapeutic RNA to the Bone Marrow in Multiple Myeloma Using CD38‐Targeted Lipid Nanoparticles (Adv. Sci. 21/2023). Advanced Science. 10(21). 2 indexed citations
8.
Kon, Edo, Yinon Levy, Uri Elia, et al.. (2023). A single-dose F1-based mRNA-LNP vaccine provides protection against the lethal plague bacterium. Science Advances. 9(10). eadg1036–eadg1036. 61 indexed citations
9.
Hazan‐Halevy, Inbal, Meir Goldsmith, Lior Stotsky‐Oterin, et al.. (2023). Delivery of Therapeutic RNA to the Bone Marrow in Multiple Myeloma Using CD38‐Targeted Lipid Nanoparticles. Advanced Science. 10(21). e2301377–e2301377. 35 indexed citations
10.
Goldsmith, Meir, Srinivas Ramishetti, Nuphar Veiga, et al.. (2021). Therapeutic inhibitory RNA in head and neck cancer via functional targeted lipid nanoparticles. Journal of Controlled Release. 337. 378–389. 41 indexed citations
11.
Dammes, Niels, Meir Goldsmith, Srinivas Ramishetti, et al.. (2021). Conformation-sensitive targeting of lipid nanoparticles for RNA therapeutics. Nature Nanotechnology. 16(9). 1030–1038. 122 indexed citations
12.
Aday, Sezin, Inbal Hazan‐Halevy, Aránzazu Chamorro-Jorganes, et al.. (2021). Bioinspired artificial exosomes based on lipid nanoparticles carrying let-7b-5p promote angiogenesis in vitro and in vivo. Molecular Therapy. 29(7). 2239–2252. 57 indexed citations
13.
Veiga, Nuphar, Meir Goldsmith, Yael Diesendruck, et al.. (2019). Leukocyte-specific siRNA delivery revealing IRF8 as a potential anti-inflammatory target. Journal of Controlled Release. 313. 33–41. 46 indexed citations
14.
Veiga, Nuphar, Meir Goldsmith, Daniel Rosenblum, et al.. (2018). Cell specific delivery of modified mRNA expressing therapeutic proteins to leukocytes. Nature Communications. 9(1). 249 indexed citations
15.
Ramishetti, Srinivas, Ranit Kedmi, Meir Goldsmith, et al.. (2015). Systemic Gene Silencing in Primary T Lymphocytes Using Targeted Lipid Nanoparticles. ACS Nano. 9(7). 6706–6716. 160 indexed citations
16.
Landesman‐Milo, Dalit, Meir Goldsmith, Shani Leviatan Ben‐Arye, et al.. (2012). Hyaluronan grafted lipid-based nanoparticles as RNAi carriers for cancer cells. Cancer Letters. 334(2). 221–227. 55 indexed citations
17.
Solmesky, Leonardo J., et al.. (2011). Assessing cellular toxicities in fibroblasts upon exposure to lipid-based nanoparticles: a high content analysis approach. Nanotechnology. 22(49). 494016–494016. 20 indexed citations
18.
Goldsmith, Meir, et al.. (2010). A ceramide analog inhibits cPLA2 activity and consequent PGE2 formation in LPS-stimulated macrophages. Immunology Letters. 135(1-2). 136–143. 16 indexed citations
19.
Goldsmith, Meir, et al.. (2009). Synergistic IL-10 induction by LPS and the ceramide-1-phosphate analog PCERA-1 is mediated by the cAMP and p38 MAP kinase pathways. Molecular Immunology. 46(10). 1979–1987. 29 indexed citations
20.
Goldsmith, Meir, Dorit Avni, Orna Ernst, et al.. (2008). A ceramide‐1‐phosphate analogue, PCERA‐1, simultaneously suppresses tumour necrosis factor‐α and induces interleukin‐10 production in activated macrophages. Immunology. 127(1). 103–115. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jeonghwan Kim Breakdown of academic impact, for papers by Yuriko Higuchi Breakdown of academic impact, for papers by Sean A. Dilliard Breakdown of academic impact, for papers by Ying‐Li Luo Breakdown of academic impact, for papers by Thomas Schluep Breakdown of academic impact, for papers by Xiangang Huang Breakdown of academic impact, for papers by Scott Barros Breakdown of academic impact, for papers by Srinivas Ramishetti Breakdown of academic impact, for papers by Anna Riccioli Breakdown of academic impact, for papers by Xinyao Du
Rankless by CCL
2026